Authors: SENDEROWICZ AM HEADLEE D STINSON SF LUSH RM KALIL N VILLALBA L HILL K STEINBERG SM FIGG WD TOMPKINS A ARBUCK SG SAUSVILLE EA

Citation: Am. Senderowicz et al., PHASE-I TRIAL OF CONTINUOUS-INFUSION FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, IN PATIENTS WITH REFRACTORY NEOPLASMS, Journal of clinical oncology, 16(9), 1998, pp. 2986-2999